188 related articles for article (PubMed ID: 17457609)
21. Contrasting activities of estrogen receptor beta isoforms in triple negative breast cancer.
Yan S; Dey P; Ziegler Y; Jiao X; Kim SH; Katzenellenbogen JA; Katzenellenbogen BS
Breast Cancer Res Treat; 2021 Jan; 185(2):281-292. PubMed ID: 33001337
[TBL] [Abstract][Full Text] [Related]
22. Potential clinical significance of ERβ ON promoter methylation in sporadic breast cancer.
Božović A; Markićević M; Dimitrijević B; Jovanović Ćupić S; Krajnović M; Lukić S; Mandušić V
Med Oncol; 2013; 30(3):642. PubMed ID: 23794253
[TBL] [Abstract][Full Text] [Related]
23. Estrogen receptor alpha-negative breast cancer tissues express significant levels of estrogen-independent transcription factors, ERbeta1 and ERbeta5: potential molecular targets for chemoprevention.
Poola I; Fuqua SA; De Witty RL; Abraham J; Marshallack JJ; Liu A
Clin Cancer Res; 2005 Oct; 11(20):7579-85. PubMed ID: 16243834
[TBL] [Abstract][Full Text] [Related]
24. Nuclear and cytoplasmic expression of ERbeta1, ERbeta2, and ERbeta5 identifies distinct prognostic outcome for breast cancer patients.
Shaaban AM; Green AR; Karthik S; Alizadeh Y; Hughes TA; Harkins L; Ellis IO; Robertson JF; Paish EC; Saunders PT; Groome NP; Speirs V
Clin Cancer Res; 2008 Aug; 14(16):5228-35. PubMed ID: 18698041
[TBL] [Abstract][Full Text] [Related]
25. The changes of estrogen receptor-beta variants expression in breast carcinogenesis: Decrease of estrogen receptor-beta2 expression is the key event in breast cancer development.
Park BW; Kim KS; Heo MK; Yang WI; Kim SI; Kim JH; Kim GE; Lee KS
J Surg Oncol; 2006 May; 93(6):504-10. PubMed ID: 16615154
[TBL] [Abstract][Full Text] [Related]
26. ERbeta isoform expression in colorectal carcinoma: an in vivo and in vitro study of clinicopathological and molecular correlates.
Wong NA; Malcomson RD; Jodrell DI; Groome NP; Harrison DJ; Saunders PT
J Pathol; 2005 Sep; 207(1):53-60. PubMed ID: 15954165
[TBL] [Abstract][Full Text] [Related]
27. Identification of wild type and variants of oestrogen receptors in polymorphonuclear and mononuclear leucocytes.
Stygar D; Westlund P; Eriksson H; Sahlin L
Clin Endocrinol (Oxf); 2006 Jan; 64(1):74-81. PubMed ID: 16402932
[TBL] [Abstract][Full Text] [Related]
28. Quantitative profile of estrogen receptor variants/isoforms in Taiwanese women with breast cancer.
Hsiao WC; Cho WC; Lin PW; Lin SL; Lee WY; Young KC
Eur J Surg Oncol; 2006 Jun; 32(5):492-7. PubMed ID: 16551498
[TBL] [Abstract][Full Text] [Related]
29. High Estrogen Receptor β Expression Is Prognostic among Adjuvant Chemotherapy-Treated Patients-Results from a Population-Based Breast Cancer Cohort.
Elebro K; Borgquist S; Rosendahl AH; Markkula A; Simonsson M; Jirström K; Rose C; Ingvar C; Jernström H
Clin Cancer Res; 2017 Feb; 23(3):766-777. PubMed ID: 27810901
[TBL] [Abstract][Full Text] [Related]
30. Estradiol Regulates mRNA Levels of Estrogen Receptor Beta 4 and Beta 5 Isoforms and Modulates Human Granulosa Cell Apoptosis.
Pierre A; Mayeur A; Marie C; Cluzet V; Chauvin J; Frydman N; Grynberg M; Cohen-Tannoudji J; Guigon CJ; Chauvin S
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34068748
[TBL] [Abstract][Full Text] [Related]
31. A laminin-rich basement membrane matrix influences estrogen receptor beta expression and morphology of MDA-MB-231 breast cancer cells.
Neubauer H; Ruoff A; Paessler N; Solomayer E; Wallwiener D; Fehm T
Oncol Rep; 2009 Feb; 21(2):475-81. PubMed ID: 19148525
[TBL] [Abstract][Full Text] [Related]
32. The expression of ERalpha, ERbeta and PR in lobular carcinoma in situ of the breast determined using laser microdissection and real-time PCR.
Green AR; Young P; Krivinskas S; Rakha EA; Claire Paish E; Powe DG; Ellis IO
Histopathology; 2009 Mar; 54(4):419-27. PubMed ID: 19309393
[TBL] [Abstract][Full Text] [Related]
33. Molecular assay to generate expression profile of eight estrogen receptor alpha isoform mRNA copy numbers in picogram amounts of total RNA from breast cancer tissues.
Poola I
Anal Biochem; 2003 Mar; 314(2):217-26. PubMed ID: 12654308
[TBL] [Abstract][Full Text] [Related]
34. The estrogen receptor alpha sigma3 mRNA splicing variant is differentially regulated by estrogen and progesterone in the rat uterus.
Varayoud J; Ramos JG; Monje L; Bosquiazzo V; Muñoz-de-Toro M; Luque EH
J Endocrinol; 2005 Jul; 186(1):51-60. PubMed ID: 16002535
[TBL] [Abstract][Full Text] [Related]
35. ERβ1 Sensitizes and ERβ2 Desensitizes ERα-Positive Breast Cancer Cells to the Inhibitory Effects of Tamoxifen, Fulvestrant and Their Combination with All-Trans Retinoic Acid.
Meligova AK; Siakouli D; Stasinopoulou S; Xenopoulou DS; Zoumpouli M; Ganou V; Gkotsi EF; Chatziioannou A; Papadodima O; Pilalis E; Alexis MN; Mitsiou DJ
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835157
[TBL] [Abstract][Full Text] [Related]
36. Oestrogen receptor beta isoform expression in sporadic colorectal cancer, familial adenomatous polyposis and progressive stages of colorectal cancer.
Stevanato Filho PR; Aguiar Júnior S; Begnami MD; Kuasne H; Spencer RM; Nakagawa WT; Bezerra TS; Kupper BC; Takahashi RM; Barros Filho M; Rogatto SR; Lopes A
BMC Cancer; 2017 Nov; 17(1):754. PubMed ID: 29132333
[TBL] [Abstract][Full Text] [Related]
37. Effects of exon-deleted estrogen receptor beta transcript variants on growth, apoptosis and gene expression of human breast cancer cell lines.
Treeck O; Juhasz-Boess I; Lattrich C; Horn F; Goerse R; Ortmann O
Breast Cancer Res Treat; 2008 Aug; 110(3):507-20. PubMed ID: 17876701
[TBL] [Abstract][Full Text] [Related]
38. Cloning, expression and functional characterization on vitellogenesis of estrogen receptors in Scatophagus argus.
Cui XF; Zhao Y; Chen HP; Deng SP; Jiang DN; Wu TL; Zhu CH; Li GL
Gen Comp Endocrinol; 2017 May; 246():37-45. PubMed ID: 28322764
[TBL] [Abstract][Full Text] [Related]
39. Nuclear and cytoplasmic expressions of ERβ1 and ERβ2 are predictive of response to therapy and alters prognosis in familial breast cancers.
Yan M; Rayoo M; Takano EA; ; Fox SB
Breast Cancer Res Treat; 2011 Apr; 126(2):395-405. PubMed ID: 20490651
[TBL] [Abstract][Full Text] [Related]
40. Estrogen receptors β1 and β2 are associated with distinct responses of estrogen receptor α-positive breast carcinoma to adjuvant endocrine therapy.
Dhimolea E; Tiniakos DG; Chantzi ΝΙ; Goutas N; Vassilaros SD; Mitsiou DJ; Alexis ΜN
Cancer Lett; 2015 Mar; 358(1):37-42. PubMed ID: 25524554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
